Scientists test Custom-Made vaccine to fight deadly brain tumor
NCT ID NCT04015700
Summary
This is a small, early-stage study testing a personalized vaccine designed to train the immune system to fight a specific type of aggressive brain cancer called glioblastoma. The main goals are to see if creating and giving this custom vaccine is safe and possible, and to check if it triggers an immune response in patients. The study is enrolling 9 adults with newly diagnosed, unmethylated glioblastoma.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.